When will AIDX.TO report earnings and why does it matter?

Healwell AI (AIDX.TO) reports fiscal Q4 on Mar 19, 2026, with a call on Mar 20. Results will update revenue, margins and cash flow, and can trigger short-term volatility given the stock's small market cap and active pre-market volume.

What is Meyka AI's outlook for AIDX.TO stock?

Meyka AI projects a quarterly model price of C$0.72 versus the current C$0.90, implying a model-based downside of -20.00%. This is a projection based on available data and not a guarantee.

What are the main risks for AIDX.TO stock investors?

Key risks include negative operating cash flow per share (-C$0.10), a current ratio of 0.85, ongoing net losses, and limited liquidity. Weak quarterly guidance could widen the downside.

How can traders manage position risk around AIDX.TO earnings?

Consider small size, tight stop losses and defined risk limits. Watch real-time volume and the Mar 20 call. Traders can also use the Base C$0.80 and Bear C$0.60 targets to size positions.

CA Stocks

AIDX.TO Healwell AI Inc. (TSX) C$0.90 Pre-Market Mar 10 2026: Earnings catalyst ahead

ByHuzaifa Zahoor March 10, 2026March 10, 2026

AIDX.TO stock trades at C$0.90 in pre-market action on 10 Mar 2026 as investors position ahead of fiscal Q4 results. The company reports on Mar 19, 2026, with a conference call on Mar 20 that can drive volume and price swings. Healwell AI Inc. (AIDX.TO) shows volume 702,538 and average volume 563,642, signaling active interest. We examine valuation, technicals, catalysts and Meyka AI’s model forecast for Canadian investors and short-term traders.